Skip to content

Category: Biotechnology

Biolog Enters the European Diagnostic Market, Bringing 45 Years of Anaerobic Culture Excellence

By API User

Biolog, a leading provider of microbial identification and phenotypic characterization tools and services, announced today that both its anaerobic media and anaerobic chambers have received CE marking, clearing the way for broader international use HAYWARD, CALIFORNIA / ACCESS Newswire / July 29, 2025 / Biolog, a leading provider of microbial identification and phenotypic characterization tools … Continued

EcoPHA Biotech Unveils World-First PHA Breakthrough at FEMS MICRO 2025 in Milan

By API User

EcoPHA Biotech Unveils World-First PHA Breakthrough at FEMS MICRO 2025Australian innovation uses Pongamia oil to produce scalable, marine-safe bioplastics Milan / Sydney – 29 July 2025 –Australian biotech leader EcoPHA has unveiled a major scientific breakthrough at FEMS MICRO 2025, one of the world’s foremost conferences in microbiology and environmental innovation, held this week in Milan, … Continued

Australian researcher awarded Gilead Sciences global grant to explore novel approach in breast cancer

By API User

Dr Aeson Chang from Monash University has been awarded 2025 Gilead Sciences Research Scholars Program grant Dr Chang becomes one of only three researchers globally to receive the 2025 grant in the Solid Tumours category Two-year funding will support research exploring the potential role of a common anti-nausea medication in improving breast cancer outcomes, following … Continued

Brandon BioCatalyst’s CUREator set to support up to 15 therapeutic biotechs thanks to funding from the Medical Research Future Fund

By API User

Brandon BioCatalyst’s CUREator set to support up to 15 therapeutic biotechs thanks to funding from the Medical Research Future Fund   Melbourne, Wednesday 16 July:  Brandon BioCatalyst’s national biotech incubator, CUREator, is set to deliver a program with support from CSIRO that will assist Australian biotechs developing novel therapeutics across the preclinical and clinical stages … Continued

AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Disease

By API User

Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin Lead indication is non-CF bronchiectasis; ATL-105 targets disease drivers through a broad multimodal mechanism of action VILNIUS, LT / ACCESS Newswire / July 15, 2025 / AATec Medical GmbH (“AATec”), a biotech company developing a multi-product platform for the … Continued

OncoSil Medical (ASX:OSL) announces appointment of Non-Executive Director

By API User

Pancreatic cancer treatment device company OncoSil Medical Limited (ASX:OSL) is pleased to announce the appointment of Dr Thomas Duthy as a Non-Executive Director, effective 11 July 2025. Dr Duthy brings more than 21 years of experience across financial markets, corporate development, and board-level roles in the healthcare and life sciences sectors. He was previously Head … Continued

BlinkLab Expands U.S. Clinical Trial Network – University of Nebraska Medical Center Engaged as Second Site in Main Phase of FDA 510(k) Study

By API User

BlinkLab Limited (ASX:BB1) (“BlinkLab” or “the Company”) is pleased to announce the expansion of its U.S. clinical trial network with the University of Nebraska Medical Center (UNMC) engaged as the second site in the main phase of its FDA 510(k) study for BlinkLab Dx 1 – its smartphone-based diagnostic tool for early autism detection. Highlights … Continued

Taiwanese enterprises helping to make Australian health and wellbeing innovations a reality

By API User

Call continues for Australian submissions to “Go Healthy with Taiwan” 8 July 2025: The Taiwan Trade Centre in Sydney is continuing to encourage Australian health innovators, companies, entrepreneurs and researchers to make submissions to its “Go Healthy with Taiwan” campaign. The deadline for submissions is August 14, with six finalists being flown to Taiwan to … Continued

OncoSil (ASX:OSL) Completion of Recruitment in PANCOSIL Study

By API User

Highlights:  Patient recruitment for the PANCOSIL trial has now been successfully completed.  This trial is an important part of OncoSil Medical’s well-articulated clinical development strategy.  The primary objective of the PANCOSIL trial is to assess a novel delivery method for the OncoSil™ device via a CT-guided percutaneous approach. OncoSil Medical expects preliminary data from the PANCOSIL study to … Continued

BlinkLab (ASX:BB1) Receives U.S. Ethics Approval to Commence Main Phase of FDA 510(k) Diagnostic Trial for Autism

By API User

30 June 2025 – Perth, Australia | BlinkLab Limited (ASX:BB1), a digital health company developing AI-powered smartphone-based diagnostic technology for autism and ADHD, is pleased to announce that it has received Institutional Review Board (IRB) ethics approval from the WIRB-Copernicus Group (WCG) for commencing the main phase of its United States FDA 510(k) clinical trial … Continued